Biosig (NASDAQ: BSGM) subsidiary ViralClear Pharmaceuticals CEO Interviewed on "The Claman Countdown" FOX BUSINESS
Spin-off, Mayo Clinic Involvement and the Team Behind the Scenes
"Biosig has a relationship with the Mayo Clinic through its PURE EP product program. This link to a Viromax conference call transcript mentions the Ma...
Potential Big Pharma Acquisition Target. Full Report Will Be Available Soon.
NASDAQ Biopharma Potential Value Opportunity Potential Big Pharma Acquisition Target Shares may be ready to run Good day everyone, These are turbulent...
Tiny float, recent R/S, Junior gold miner in the Cortez Trend, with all-star management (NASDAQ: USAU) News out today as well!
This Junior Gold Miner has Struck Gold
Tiny Float Biopharma Stock Exhibiting Value and Paying a Stock Dividend Real Soon
Tiny Float Biopharma Stock Exhibiting Value Spherix is paying a stock dividend real soon Good day everyone, Today we are initiating coverage of Spheri...
Potential New Tech in Treatment of Disease
Good day everyone, As you know we cover many biotech stocks. We’ve talked about companies developing pharma products with big potential. We’ve talked ...
Traders News Source Remains One of The Most Sought After Small Cap Stock Newsletters. Over 1000% in Bookable Gains This Year so Far
Traders News Source Remains One of The Most Sought After Small Cap Stock Newsletters Over 1000% in Bookable Gains This Year so Far Updates and what to...
Biotech Stocks are Surging in 2020. Over 500% in Realistic Bookable Gains Since December 2019 for our Members!
"The iShares Nasdaq Biotechnology ETF was up about 27% in 2019 with a large part of that gain coming in Q4. Many of the biotech stocks we follow tr...
Recent news of a potential pandemic has given (NASDAQ: CTXR) even more credence with Mino-Lok
Could This Be the Hottest Biopharma Stock of 2020? CTXR’s lead product could be the enemy of infections. Good day everyone, We are continuing our cove...
Biopharma Company Looking Ready to Run, Full Report
Biopharma Company Ready to Run ATNM product picked for HIV clinical trial Good day everyone, Today we are revisiting a stock we covered a couple weeks...